Increased subcutaneous insulin requirements in diabetic patients recently commenced on peritoneal dialysis

Nephrology Dialysis Transplantation

Volumn 22, Issue 6, 2007, Pages 1697-1702

  Szeto, Cheuk Chun ^a   Chow, Kai Ming ^a   Leung, Chi Bon ^a   Kwan, Bonnie Ching Ha ^a   Chung, Kwok Yi ^a   Law, Man Ching ^a   Li, Philip Kam Tao ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Glucose; Obesity; Renal failure

Indexed keywords

CREATININE; GLUCOSE; HEMOGLOBIN; INSULIN;

ADULT; AGED; ARTICLE; BODY MASS; CONFIDENCE INTERVAL; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC NEPHROPATHY; DIET RESTRICTION; DRUG DOSE INCREASE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; STUDENT T TEST; TREATMENT DURATION;

DIABETES MELLITUS; DIABETIC NEPHROPATHIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HUMANS; INJECTIONS, SUBCUTANEOUS; INSULIN; MALE; MIDDLE AGED; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY;

EID: 34447577033     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfl834     Document Type: Article

References (29)

1. Scarpioni L, Ballocchi S, Scarpioni R, Cristinelli L. Peritoneal dialysis in diabetics. Optimal insulin therapy on CAPD: Intraperitoneal versus subcutaneous treatment. Perit Dial Int 1996; 16 [Suppl 1]: S275-S278
2. Chan E, Montgomery PA. Administration of insulin by continuous ambulatory peritoneal dialysis. Pharmacotherapy 1993; 13: 455-460
3. Quellhorst E. Insulin therapy during peritoneal dialysis: Pros and cons of various forms of administration. J Am Soc Nephrol 2002; 13 [Suppl 1]: S92-S96
4. Nevalainen P, Lahtela JT, Mustonen J, Pasternack A. The influence of peritoneal dialysis and the use of subcutaneous and intraperitoneal insulin on glucose metabolism and serum lipids in type 1 diabetic patients. Nephrol Dial Transplant 1997; 12: 145-150
5. Ruotolo G, Micossi P, Galimberti G et al. Effects of intraperitoneal versus subcutaneous insulin administration on lipoprotein metabolism in type I diabetes. Metabolism 1990; 39: 598-604
6. Ruotolo G, Parlavecchia M, Taskinen MR et al. Normalization of lipoprotein composition by intraperitoneal insulin in IDDM. Diabetes Care 1994; 17: 6-12
7. Georgopoulos A, Saudek CD. Normalization of composition of triglyceride-rich lipoprotein subfractions in diabetic subjects during insulin infusion with programmable implantable medication system. Diabetes Care 1992; 15: 19-26
8. Bagdade JD, Dunn FL, Eckel RH, Ritter MC. Intraperitoneal insulin therapy corrects abnormalities in cholesteryl ester transfer and lipoprotein lipase activities in insulin-dependent diabetes mellitus. Arterioscler Thromb 1994; 14: 1933-1939
9. Selgas R, Diez JJ, Munoz J, Miranda B, de Alvaro F, Rodriguez JC. Comparative study of two different routes for insulin administration in CAPD diabetic patients. A multicenter study. Adv Perit Dial 1989; 5: 181-184
10. Scarpioni L, Ballocchi S, Cristinelli L, Scarpioni R. Insulin therapy in uremic diabetic patients on continuous ambulatory peritoneal dialysis; comparison of intraperitoneal and subcutaneous administration. Perit Dial Int 1994; 14: 127-131
11. Beddhu S, Zeidel ML, Saul M et al. The effects of comorbid conditions on the outcomes of patients undergoing peritoneal dialysis. Am J Med 2002; 112: 696-701
12. Twardowski ZJ, Nolph KD, Prowant B, Ryan L, Moore H, Nielsen MP. Peritoneal equilibration test. Peritoneal Dial Bull 1987; 7: 138-147
13. Mak TW, Cheung CK, Cheung CM, Leung CB, Lam CW, Lai KN. Interference of creatinine measurement in CAPD fluid was dependent on glucose and creatinine concentrations. Nephrol Dial Transplant 1997; 12: 184-186
14. Krediet RT, Boeschoten EW, Zuyderhoudt FMJ, Strackee J, Arisz L. Simple assessment of the efficacy of peritoneal transport in continuous ambulatory peritoneal dialysis patients. Blood Purif 1986, 4: 194-203
15. Noe DA. A body surface area nomogram based on the formula of Gehan and George. J Pharm Sci 1991; 80: 501
16. Amair P, Khanna R, Leibel B et al. Continuous ambulatory peritoneal dialysis in diabetics writh end-stage renal disease. N Engl J Med 1982; 306: 625-630
17. Nevalainen PI, Lahtela JT, Mustonen J, Pasternack A. Subcutaneous and intraperitoneal insulin therapy in diabetic patients on CAPD. Perit Dial Int 1996; 16 [Suppl 1]: S288-S291
18. Tuzcu A, Bahceci M, Yilmaz ME, Turgut C, Kara IH. The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease. Saudi Med J 2005; 26: 786-791
19. Amici G, Orrasch M, Da Rin G, Bocci C. Hyperinsulinism reduction associated with icodextrin treatment in continuous ambulatory peritoneal dialysis patients. Adv Perit Dial 2001; 17: 80-83
20. Tzamaloukas AH, Friedman EA. Diabetes. In: Daugirdas JT, Blake PG, Ing TS, eds. Handbook of Dialysis, 3rd edn, Lippincott Williams & Wilkins, Philadelphia: 2001
21. Szeto CC, Lai KN, Yu AW et al. Dialysis adequacy of Asian patients receiving small volume continuous ambulatory peritoneal dialysis. Int J Artif Organs 1997: 20: 428-435
22. Szeto CC, Wong TY, Leung CB et al. Importance of dialysis adequacy in mortality and morbidity of Chinese CAPD patients. Kidney Int 2000; 58: 400-407
23. National Kidney Foundation.NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: Update 2000. Am J Kidney Dis 2001; 37 [Suppl 1]: S182-S238
24. Locatelli F, Aljama P, Barany P et al. Revised European Best Practice Guidelines for the management of anaemia in patients with chronic renal failure. Nephrol Dial Transplant 2004; 19 [Suppl 2]: 1-47
25. Sit D, Kadiroglu AK, Yilmaz ME, Kara IH, Isikoglu B. The prevalence of insulin resistance and its relationship between anemia, secondary hyperparathyroidism, inflammation, and cardiac parameters in chronic hemodialysis patients. Ren Fail 2005; 27: 403-407
26. Mak RH. Correction of anemia by erythropoietin reverses insulin resistance and hyperinsulinemia in uremia. Am J Physiol 1996; 270: F839-F844
27. Ko GT, Tang J, Chan JC et al. Lower BMI cut-off value to define obesity in Hong Kong Chinese: An analysis based on body fat assessment by bioelectrical impedance. Br J Nutr 2001; 85: 239-242
28. Szeto CC, Law MC, Wong TY, Leung CB, Li PK. Peritoneal transport status correlate with morbidity but not longitudinal change of nutritional status of continuous ambulatory peritoneal dialysis patients - A two-year prospective study. Am J Kidney Dis 2001; 37: 329-336
29. Szeto CC, Wong TY, Chow KM, Leung CB, Li PK. Dialysis adequacy and transport test for characterization of peritoneal transport type in Chinese peritoneal dialysis patients receiving three daily exchanges. Am J Kidney Dis 2002; 39: 1287-1299